Response to: reassessing formulary changes

Regional Anesthesia & Pain Medicine 2026

View at publisher
Authors: Brian Daniel Sites, Anuj B Patel, Matthew A. Davis, Gerard Kerins, Timothy M. Millington, Yvon F. Bryan
DOI: 10.1136/rapm-2025-107529
Cited by: 0
References: 2

Abstract

We thank Drs Mistry and Nair for their interest in our recent publication examining the implications of removing liposomal bupivacaine from an academic hospital formulary.[1 2][1] Their five itemized comments can be reasonably distilled into two overarching themes. First, they highlight the inherent

Fields of Study & Subjects

Anesthesia and Pain Management Pain Management and Opioid Use Pharmaceutical studies and practices

Publication details

Journal / source
Regional Anesthesia & Pain Medicine
Pages
rapm–2025
Publication date
6 January 2026
Language
EN